Visual Plasticity Following Brain Lesions
VIBRANT
Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training
1 other identifier
interventional
30
1 country
1
Brief Summary
The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways. It aims to investigate whether transcranial random noise stimulation (tRNS) combined with perceptual learning-based training has potential for improving visual impairments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2025
CompletedStudy Start
First participant enrolled
July 17, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
August 5, 2025
July 1, 2025
3 years
July 11, 2025
July 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Motion Discrimination Performance
Change in accuracy on a computerized motion direction discrimination task programmed in the lab. The task assesses participants' ability to discriminate the direction of the peripherally presented moving dots at two locations (one within the blind field and the other at a mirror-symmetric location in the intact visual field). Accuracy is defined as the proportion of correct responses out of the total number of trials completed.
Study visit 1 to 2 (within a week), and study visit 3 to 4 (within a week)
Secondary Outcomes (3)
Visual Field Change
Baseline (pre-intervention) to post-intervention follow-up (approximately 3 months, up to 6 months)
Visual Perception Change
Baseline (pre-intervention) to post-intervention follow-up (approximately 3 months, up to 6 months)
Quality of Life Change
Baseline (pre-intervention) to post-intervention follow-up (approximately 3 months, up to 6 months)
Study Arms (2)
tRNS with perceptual learning-based training
EXPERIMENTALEach 2-day session consists of up to three 18-minute transcranial random noise stimulation (tRNS) paired with perceptual learning-based training.
Sham with perceptual learning-based training
SHAM COMPARATOREach 2-day session consists of up to three 18-minute sham stimulation paired with perceptual learning-based training.
Interventions
Stimulation location: bilateral human middle temporal complex (hMT+). Stimulation parameters: 1 mA current intensity, with a frequency range of 101-640 Hz.
Stimulation location: bilateral human middle temporal complex (hMT+). Stimulation parameters: Ramp up stimulation at 1mA with a frequency range of 101-640Hz for the first 30 seconds followed by no current for the remainder of the duration.
A motion discrimination task, judging the global direction of moving dot stimuli with two different coherence levels.
Eligibility Criteria
You may qualify if:
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures.
- Unilateral or bilateral focal brain damage causing loss of vision.
- At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
You may not qualify if:
- Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
- Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
- Vision loss resulting from ocular disease or disorder.
- B. Healthy volunteers (age-matched controls):
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures.
- Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.
- Previous head injury.
- Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Georgetown University Medical Center
Washington D.C., District of Columbia, 20057, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- This study is double-blind, meaning that both the participants and the researchers will be blinded to the treatment conditions.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2025
First Posted
August 5, 2025
Study Start
July 17, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
August 5, 2025
Record last verified: 2025-07